In the future, the relationship between the osteoporosis microenvironment and TRPV5 will be more clearly elucidated, and drug development or disease diagnostic criteria centered on TRPV5 ion channels will provide more favorable conditions for the treatment of osteoporosis. The gene discussed is TRPV5; the disease is osteoporosis.